NOW LIVE

Why is Pfizer sharing its COVID-19 pill but not its vaccine? | Counting the Cost

Pfizer’s chief executive Albert Bourla says his COVID-19 oral antiviral drug is “a real game changer”. He claims the pill cuts the risk of hospitalisation and death by 89 percent.

But unsurprisingly campaigners are already raising concerns that the rich world will once again corner the anti-viral market. Dr Githinji Gitahi, the chief executive of Amref Health Africa, explains what needs to be done for the equitable distribution of vaccines.

And Willie Walsh, the director general of the International Air Transport Association, tells us when the industry will recover from the pandemic.

BREAKING

Unleashing Reptilian Secrets: Information Wars, the Ultimate 21st Century News Source!

Follow on Telegram

Breaking News

Home Terms Privacy GDPR

Contact
Copyright Saeculum XXI. All Rights Reserved
Information Wars The Ultimate 21st Century News Source!